Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Severe severity 		Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
Severe severity 		Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Severe severity 		Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
Bamlanivimab
Severe severity 		Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Convalescent plasma
Severe severity 		Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Severe severity 		Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Severe severity 		Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Colchicine
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Dexamethasone
Severe severity 		Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
Tocilizumab
Severe severity 		Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Glucocorticoids
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Ritonavir
Severe severity 		Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Favipiravir
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Ruxolitinib
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021
IVIg
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Sarilumab 
Severe severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/29/2021
Chloroquine phosphate
Severe severity 		Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Export (.csv)